A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
Clinical trial NCT03548584 · COMPLETED
Trial details
- NCT number
- NCT03548584
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2022-05-23
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.